Authors:
Edman, K
Svensson, L
Eriksson, B
Gunnarsson, PO
Citation: K. Edman et al., Determination of estramustine phosphate and its metabolites estromustine, estramustine, estrone and estradiol in human plasma by liquid chromatography with fluorescence detection and gas chromatography with nitrogen-phosphorus and mass spectrometric detection, J CHROMAT B, 738(2), 2000, pp. 267-279
Citation: Cj. Johansson et Po. Gunnarsson, Pharmacodynamic model of testosterone suppression after intramuscular depot estrogen therapy in prostate cancer, PROSTATE, 44(1), 2000, pp. 26-30
Authors:
Strandgarden, K
Hoglund, P
Gronquist, L
Svensson, L
Gunnarsson, PO
Citation: K. Strandgarden et al., Absorption and disposition including enterohepatic circulation of (C-14) roquinimex after oral administration to healthy volunteers, BIOPHARM DR, 21(2), 2000, pp. 53-67
Authors:
Tuvesson, H
Wienkers, LC
Gunnarsson, PO
Seidegard, J
Persson, R
Citation: H. Tuvesson et al., Identification of cytochrome P4503A as the major subfamily responsible forthe metabolism of roquinimex in man, XENOBIOTICA, 30(9), 2000, pp. 905-914
Authors:
Eriksson, B
Hallstrom, G
Brorsson, AKO
Svensson, L
Gunnarsson, PO
Citation: B. Eriksson et al., Metabolic fate of delmopinol in man after mouth rinsing and after oral administration, XENOBIOTICA, 30(2), 2000, pp. 179-192
Authors:
Henriksson, P
Carlstrom, K
Pousette, A
Gunnarsson, PO
Johansson, CJ
Eriksson, B
Altersgard-Brorsson, AK
Nordle, O
Stege, R
Citation: P. Henriksson et al., Time for revival of estrogens in the treatment of advanced prostatic carcinoma? Pharmacokinetics, and endocrine and clinical effects, of a parenteralestrogen regimen, PROSTATE, 40(2), 1999, pp. 76-82
Authors:
Strandgarden, K
Hoglund, P
Nordle, O
Polacek, J
Wannman, H
Gunnarsson, PO
Citation: K. Strandgarden et al., Dissolution rate-limited absorption and complete bioavailability of roquinimex in man, BIOPHARM DR, 20(7), 1999, pp. 347-354